Gyorgy Snell to Drug Design
This is a "connection" page, showing publications Gyorgy Snell has written about Drug Design.
Connection Strength
0.163
-
Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors. Bioorg Med Chem. 2018 02 01; 26(3):647-660.
Score: 0.073
-
Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design. Bioorg Med Chem. 2017 09 01; 25(17):4876-4886.
Score: 0.071
-
Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile. Bioorg Med Chem. 2018 07 23; 26(12):3261-3286.
Score: 0.019